Home > Quotes > ONXX > Company News
ONXX

ONYX Pharmaceuticals, Inc. News Headlines

$94.34
*  
1.31
  negative  
1.37%
Get ONXX Alerts
*Delayed - data as of May 20, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Bayer Submits Regorafenib in Japan - Analyst Blog
12/28/2012 12:20:01 PM - Zacks.com

A Look Back At The Year In Biotech (MDVN, ONXX, ARNA, SRPT)
12/28/2012 12:15:00 PM - Investopedia

Back to Neutral on Bayer - Analyst Blog
12/26/2012 2:15:01 PM - Zacks.com

Upcoming FDA Decision For AVEO's Tivozanib Builds Speculation
12/21/2012 6:14:00 PM - Seeking Alpha

Oncolytics Biotech: What Is All The Excitement About?
12/18/2012 10:44:00 AM - Seeking Alpha

Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disaster
12/10/2012 11:20:00 AM - Seeking Alpha

Onyx Pharmaceuticals (ONXX) - Bull of the Day
12/5/2012 1:00:01 AM - Zacks.com

5 Recently Approved Cancer Drugs To Watch In 2013
12/3/2012 3:55:00 PM - Seeking Alpha

How pharma investor guards profits
11/29/2012 5:47:31 AM - optionMONSTER

Upcoming Catalyst Event For Aveo Pharma May Provoke Short Covering
11/21/2012 8:45:00 AM - Seeking Alpha

Upcoming BioPharma Catalyst Trades to Consider
11/15/2012 1:32:17 PM - Trefis

It's Time To Buy Back Celgene On Abraxane
11/14/2012 1:05:00 PM - Seeking Alpha

EU Nod for Novartis' Votubia - Analyst Blog
11/13/2012 11:20:01 AM - Zacks.com

3 Biopharma Catalyst Trades To Consider
11/13/2012 4:55:00 AM - Seeking Alpha

ASH 2012 Preview: Top Picks For Upcoming Blood Cancer Meeting
11/12/2012 8:20:00 AM - Seeking Alpha

Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus
11/11/2012 2:07:00 AM - Seeking Alpha

Onyx Beats Expectations - Analyst Blog
11/6/2012 5:00:01 PM - Zacks.com

Edward Owens' Vanguard Health Care Fund Does More Shedding Than Adding in Third Quarter
11/1/2012 7:26:05 PM - GuruFocus

Priority FDA Review for Stivarga - Analyst Blog
10/31/2012 2:27:54 PM - Zacks.com

Sales Swell at Celgene - Analyst Blog
10/25/2012 12:41:01 PM - Zacks.com

Onyx Enrolls FOCUS Patients - Analyst Blog
10/22/2012 4:29:35 PM - Zacks.com

Celgene's Pipeline Offers Catalysts Into 2013
10/3/2012 6:33:00 PM - Seeking Alpha

Pfizer, Novartis And Northwest Biotherapeutics In A Race For IVF Inspired Cancer Cure
10/2/2012 10:20:00 AM - Seeking Alpha

Bayer's Stivarga Gains Approval - Analyst Blog
9/28/2012 5:25:01 PM - Zacks.com

Cramer's Lightning Round - I Like Silver, But I Like Gold More (9/27/12)
9/28/2012 7:02:00 AM - Seeking Alpha